Axis-Shield Ltd Stock

Stocks

Delayed London S.E.			5-day change	1st Jan Change
- ^GBX	-.--%		-.--%	-

20-07-29	Axis Shield : The Effect of Food Intake on the Pharmacokinetics of Vadadustat Following Single Dose Administration	PU
20-07-29	Axis Shield : Randomized, Double-Blinded, Active-Controlled (Darbepoetin Alfa), Phase 3 Study of Vadadustat in Chronic Kidney Disease Patients With Anemia on Hemodialysis in Japan	PU
20-07-29	Axis Shield : Preclinical Characterization of Vadadustat (AKB-6548), an Oral Small Molecule Hypoxia Inducible Factor Prolyl-4-Hydroxylase Inhibitor, for the Potential Treatment of Renal Anemia	PU
20-07-29	Axis Shield : Targeted Literature Review of Patient-reported Burden of Anemia in Chronic Kidney Disease	PU
20-07-29	Efficacy and Safety of Vadadustat, an Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor, Being Evaluated for the Treatment of Anemia Due to Chronic Kidney Disease (CKD) in Japanese Subjects: Results from Phase 2 Studies (encore)	PU

Manager	Title	Age	Since
Erling M. H. Sundrehagen CTO	Chief Tech/Sci/R&D Officer	74	1983-12-31
Atle Schjøtt PRN	Corporate Officer/Principal	-	2010-09-19
Guido Schilling PRN	Corporate Officer/Principal	-	2010-09-19

Director	Title	Age	Since
Erling M. H. Sundrehagen BRD	Director/Board Member	74	1983-12-31
David Andrew Bond BRD	Director/Board Member	55	-
Brian Yoor BRD	Director/Board Member	56	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AXIS-SHIELD LTD	-.--%	-.--%	-	-	0
ABBOTT LABORATORIES	-1.06%	-5.38%	-13.94%	+16.30%	189B
MEDTRONIC PLC	+0.02%	-3.19%	+6.51%	+43.76%	124B
STRYKER CORPORATION	-1.70%	-6.14%	-12.35%	+16.51%	121B
ESSILORLUXOTTICA	-0.79%	-5.67%	-43.54%	+2.44%	93.09B
CENCORA, INC.	+0.34%	-1.16%	-4.16%	+77.09%	66.77B
BECTON, DICKINSON AND COMPANY	+0.90%	+2.55%	+13.49%	-8.58%	58.43B
IDEXX LABORATORIES, INC.	+0.85%	+0.58%	-1.39%	+63.88%	55.35B
HOYA CORPORATION	+0.96%	+0.06%	-1.73%	+56.33%	49.49B
ALCON INC.	+2.12%	-2.90%	-4.84%	-7.10%	34.53B
Average	+0.16%	-2.09%	-6.88%	+28.96%	79B
Weighted average by Cap.	-0.30%	-3.10%	-9.08%	+27.10%